Efficacy of a Spatial Repellent for Control of Malaria in Indonesia: A Cluster-Randomized Controlled Trial
A cluster-randomized, double-blinded, placebo-controlled trial was conducted to estimate the protective efficacy (PE) of a spatial repellent (SR) against malaria infection in Sumba, Indonesia. Following radical cure in 1,341 children aged ≥ 6 months to ≤ 5 years in 24 clusters, households were given...
Saved in:
Published in | The American journal of tropical medicine and hygiene Vol. 103; no. 1; pp. 344 - 358 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Institute of Tropical Medicine
01.07.2020
The American Society of Tropical Medicine and Hygiene |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A cluster-randomized, double-blinded, placebo-controlled trial was conducted to estimate the protective efficacy (PE) of a spatial repellent (SR) against malaria infection in Sumba, Indonesia. Following radical cure in 1,341 children aged ≥ 6 months to ≤ 5 years in 24 clusters, households were given transfluthrin or placebo passive emanators (devices designed to release vaporized chemical). Monthly blood screening and biweekly human-landing mosquito catches were performed during a 10-month baseline (June 2015-March 2016) and a 24-month intervention period (April 2016-April 2018). Screening detected 164 first-time infections and an accumulative total of 459 infections in 667 subjects in placebo-control households, and 134 first-time and 253 accumulative total infections among 665 subjects in active intervention households. The 24-cluster protective effect of 27.7% and 31.3%, for time to first-event and overall (total new) infections, respectively, was not statistically significant. Purportedly, this was due in part to zero to low incidence in some clusters, undermining the ability to detect a protective effect. Subgroup analysis of 19 clusters where at least one infection occurred during baseline showed 33.3% (
-value = 0.083) and 40.9% (
-value = 0.0236, statistically significant at the one-sided 5% significance level) protective effect to first infection and overall infections, respectively. Among 12 moderate- to high-risk clusters, a statistically significant decrease in infection by intervention was detected (60% PE). Primary entomological analysis of impact was inconclusive. Although this study suggests SRs prevent malaria, additional evidence is required to demonstrate the product class provides an operationally feasible and effective means of reducing malaria transmission. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 These authors contributed equally to this work. Financial support: This study was funded by a substantial award from the Bill and Melinda Gates Foundation to the University of Notre Dame (Grant #OPP1081737). We express our gratitude to the foundation for their long-term generosity and support of spatial repellent product evaluation and development, especially Kate Aultman, Dan Strickman, and Alan Magill. We are also deeply grateful to S.C. Johnson for its financial support. The company provided integral industry and product expertise, including the development, manufacturing, delivery and shipment of the interventions (active and placebo) used in the study. In addition, S.C. Johnson provided expertise in ensuring intervention quality, storage, application, and disposal assurances throughout the trial. Authors’ addresses: Din Syafruddin, Puji Asih, Ismail Ekoprayitno Rozi, Dendi Hadi Permana, Anggi Puspa Nur Hidayati, Lepa Syahrani, and Siti Zubaidah, Department of Malaria, Eijkman Institute for Molecular Biology, Jakarta, Indonesia, E-mails: din@eijkman.go.id, puji@eijkman.go.id, eko@eijkman.go.id, dendi_hp@eijkman.go.id, anggie@eijkman.go.id, lepa@eijkman.go.id, and jeihan93@yahool.com. Dian Sidik, Department of Epidemiology, Faculty of Public Health, Universitas Hasanuddin, Makassar, Indonesia, E-mail: dian_sidiq@yahoo.com. Michael J. Bangs, Public Health and Malaria Control, PT Freeport Indonesia, International SOS, Kuala Kencana, Papua, Indonesia, E-mail: mbangs@fmi.com. Claus Bøgh, The Sumba Foundation, Public Health and Malaria Control, Bali, Indonesia, E-mail: cbogh@cbn.net.id. Fang Liu and Evercita C. Eugenio, Department of Applied Mathematics, University of Notre Dame, Notre Dame, IN, E-mails: fliu2@nd.edu and eeugenio@nd.edu. Jared Hendrickson, Center for Computer Research, University of Notre Dame, Notre Dame, IN, E-mail: jhendri4@nd.edu. Timothy Burton, Frank Collins, John P. Grieco, Neil F. Lobo, and Nicole L. Achee, Department of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN, E-mails: timothy.a.burton.39@nd.edu, frank@nd.edu, jgrieco@nd.edu, nlobo@nd.edu, and nachee@nd.edu. J. Kevin Baird, Eijkman-Oxford Clinical Research Unit, Oxford University, Jakarta, Indonesia, E-mail: jkevinbaird@yahoo.com. Disclaimer: The contents are the responsibility of the authors. |
ISSN: | 0002-9637 1476-1645 1476-1645 |
DOI: | 10.4269/ajtmh.19-0554 |